HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Ramani, R. R. Articles by Zhu, B.-P. Search for Related Content PubMed PubMed Citation Articles by Ramani, R. R. Articles by Zhu, B.-P. Related Collections Immunization/Vaccines Other Infections Other Child and Adolescent Health

Revathi R. Ramani, MD, MPH, William N. Hall, MD, MPH, Matthew Boulton, MD, MPH, David R. Johnson, MD, MPH and Bao-Ping Zhu, MD, MS

At the time of the study, all the authors were with the Michigan Department of Community Health, Lansing, Mich. Revathi R. Ramani and Matthew Boulton also were with the University of Michigan Preventive Medicine Residency Program, Ann Arbor.

Correspondence: Requests for reprints should be sent to William N. Hall, Bureau of Epidemiology, Mich Dept of Community Health, 3423 N Martin Luther King Blvd, Lansing, MI 48909 (e-mail: hallw{at}michigan.gov).

We examined the impact of the heptavalent pneumococcal conjugate vaccine (PCV7) on hospital discharge rates for invasive pneumococcal disease among Michigan children younger than 5 years old. After the introduction of PCV7, the hospital discharge rate for children younger than 1 years old was significantly lower than before introduction. We correlated the decreased rates with the introduction and rapid uptake of PCV7. Lack of change in the hospital discharge rates for other age groups likely represents a slower uptake of PCV7 compared with that for children aged younger than 1 year.

This article has been cited by other articles:

				R. J. Singleton, T. W. Hennessy, L. R. Bulkow, L. L. Hammitt, T. Zulz, D. A. Hurlburt, J. C. Butler, K. Rudolph, and A. Parkinson Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes Among Alaska Native Children With High Levels of 7-Valent Pneumococcal Conjugate Vaccine Coverage JAMA, April 25, 2007; 297(16): 1784 - 1792. [Abstract] [Full Text] [PDF]

				C. G. Grijalva, K. A. Poehling, J. P. Nuorti, Y. Zhu, S. W. Martin, K. M. Edwards, and M. R. Griffin National Impact of Universal Childhood Immunization With Pneumococcal Conjugate Vaccine on Outpatient Medical Care Visits in the United States Pediatrics, September 1, 2006; 118(3): 865 - 873. [Abstract] [Full Text] [PDF]

				S. Stokley, K. M. Shaw, L. Barker, J. M. Santoli, and A. Shefer Impact of State Vaccine Financing Policy on Uptake of Heptavalent Pneumococcal Conjugate Vaccine Am J Public Health, July 1, 2006; 96(7): 1308 - 1313. [Abstract] [Full Text] [PDF]